Metraipolis › archive › dc_0ef019c05735

Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway — Europe PMC PMID:42350359

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42350359
DOI
10.1038/s41419-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-31T08:51:14.497Z
SHA-256 of the archived text
62ac2df618dbe38b4997b1aa370faaf1dd0118edafb991d29520304fec34a2a1
Stable URL of this page
https://metraipolis.com/documento/dc_0ef019c05735

How to cite

Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway — Europe PMC PMID:42350359 — Europe PMC (en), https://europepmc.org/article/MED/42350359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ef019c05735 (Metraipolis archive dc_0ef019c05735, sha256 62ac2df618dbe38b4997b1aa370faaf1dd0118edafb991d29520304fec34a2a1)
BibTeX
@misc{dc0ef019c05735,
  title = {Deubiquitinase USP32 stabilizes DDX17 to promote tumor progression and lenvatinib resistance in hepatocellular carcinoma via the miR-3163/MAPK pathway — Europe PMC PMID:42350359},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42350359},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ef019c05735; sha256 62ac2df618dbe38b4997b1aa370faaf1dd0118edafb991d29520304fec34a2a1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42350359. Agents can read the archived copy with the MCP tool read_document.